EMERYVILLE, Calif., Aug. 9, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Company will be reporting financial results for the second quarter 2023 after market on Monday, August 14, 2023. About PhenomeX Inc. PhenomeX is empowering scientists to leverage the full potential of each cell and drive the … Read more
EMERYVILLE, Calif., June 13, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Company’s technology was recently featured in a groundbreaking study published in Cell Reports titled “Potent Omicron-neutralizing antibodies isolated from a patient vaccinated six months before Omicron emergence” that has revealed the remarkable efficacy of vaccines in generating … Read more
Het Bedrijf toont zijn onlangs gelanceerde Beacon Select™-technologie voor de ontdekking van antilichamen en de ontwikkeling van cellijnen EMERYVILLE, Californië, 5 juni 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), het bedrijf voor functionele celbiologie, heeft vandaag bekendgemaakt van 6-8 juni 2023 in het Postillion Hotel Amsterdam aan de Antibody Engineering & Therapeutics (AE&T) Europe 2023 … Read more
Beacon Quest designed with affordable two-chip optofluidic system to accelerate the pace of scientific discovery across academic, non-profit, and government research including comprehensive single T Cell profiling, for precision immunotherapy translational research and accelerated development EMERYVILLE, Calif., June 5, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced the launch … Read more
Company to feature its recently launched Beacon Select™ technology for antibody discovery and cell line development EMERYVILLE, Calif., June 5, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced its participation in the Antibody Engineering & Therapeutics (AE&T) Europe 2023 from 6-8 June 2023 at the Postillion Hotel Amsterdam. AE&T is … Read more
Das Unternehmen stellt seine kürzlich eingeführte Beacon Select™-Technologie für die Entdeckung von Antikörpern und die Entwicklung von Zelllinien vor EMERYVILLE, Kalifornien, 5. Juni 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), das Unternehmen für funktionelle Zellbiologie, gab heute seine Teilnahme an der Antibody Engineering & Therapeutics (AE&T) Europe 2023 vom 6.-8. Juni 2023 im Postillion Hotel … Read more